Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stat5, with a Stat5 specific synergistic effect of dexamethasone

被引:32
|
作者
von Laue, S
Finidori, J
Maamra, M
Shen, XY
Justice, S
Dobson, PRM
Ross, RJM
机构
[1] Fac Med Necker Enfants, Mol Endocrinol Lab, INSERM U344, F-75730 Paris 15, France
[2] Univ Sheffield, Div Clin Sci, Sheffield, S Yorkshire, England
[3] Univ Sheffield, Inst Canc Studies, Sheffield, S Yorkshire, England
关键词
D O I
10.1677/joe.0.1650301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interaction of GH, interleukin (IL)-6 and glucocorticoids is likely to be important in regulating the GH-insulin-like growth factor (IGF)-I axis. The signalling cascades activated by GH and IL-6 appear to be very similar, as demonstrated by studies using overexpression of the receptor and other components of the Jak-Stat and mitogen-activated protein (MAP) kinase pathways. Here we Show that the human embryonic kidney cell line 293 (HEK293) expresses GH and IL-6 receptors endogenously. To determine which specific pathways might be activated by the two cytokines, at physiological levels of all components, we studied GH and IL-6 mediated signal transduction both under basal conditions and in the presence of overexpressed receptors and Stat proteins. Our results suggest a receptor specificity of Jak2 for GH receptors, and Jak1 for IL-6 receptors. Stat activation in response to GH and IL-6 was determined by reporter gene induction. Both GH and IL-6 were able to induce the reporter gene containing the Stat5 responsive element (LHRE) but the IL-6 response appeared to be mediated mainly through Stat3 activation. In contrast, the reporter gene containing the Stat3 responsive element (SIE) was IL-6 specific. The levels of gene induction by GH and IL-6 were not altered by the co-stimulation with GH and IL-6, suggesting that there is little cross-talk at the Jak-Stat activation level between the two cytokines. Neither GH nor IL-6 activated the MAP-kinase responsive serum response element (SRE), unless GH receptors or gp130 were overexpressed. Transfection of Stat3 or Stat5 expression vectors enhanced the response to GH and IL-6. Stimulation with dexamethasone synergistically enhanced GH activation of the LHRE reporter gene but had no effect on the IL-6 activation of the same reporter or on the SIE reporter gene. Thus, our studies suggest that while each cytokine, GH and IL-6, may activate various members of the Jak-Stat pathway in overexpression studies, specific activation of Stat3 by IL-6 and of Jak2 and Stat5 by GH can be observed in HEK293 cells and that in this system the synergistic effect of dexamethasone appears specific for Stat5.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 36 条
  • [21] IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells
    Rolling, C
    Treton, D
    Pellegrini, S
    Galanaud, P
    Richard, Y
    FEBS LETTERS, 1996, 393 (01) : 53 - 56
  • [22] Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway
    Qian, Yi-Hua
    Xiao, Qingli
    Chen, Hong
    Xu, Jan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (05): : 764 - 771
  • [23] Inhibition of Either HDAC5 or-6 Can Significantly Modulate the Expression of Specific Growth Hormone-Regulated STAT5 Target Genes in Adipocytes
    De Sa, Paula Mota
    Richard, Allison J.
    Stephens, Jacqueline M.
    DIABETES, 2017, 66 : A489 - A489
  • [24] Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
    Nishioka, C.
    Ikezoe, T.
    Yang, J.
    Yokoyama, A.
    LEUKEMIA, 2009, 23 (12) : 2304 - 2308
  • [25] Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
    C Nishioka
    T Ikezoe
    J Yang
    A Yokoyama
    Leukemia, 2009, 23 : 2304 - 2308
  • [26] Breakdown of the FLT3-ITD/STAT5 Axis and Synergistic Apoptosis Induction by the Histone Deacetylase Inhibitor Panobinostat and FLT3-Specific Inhibitors
    Pietschmann, Kristin
    Bolck, Hella Anna
    Buchwald, Marc
    Spielberg, Steffi
    Polzer, Harald
    Spiekermann, Karsten
    Bug, Gesine
    Heinzel, Thorsten
    Boehmer, Frank-Dietmar
    Kraemer, Oliver H.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) : 2373 - 2383
  • [27] ESTRADIOL AND TESTOSTERONE POTENTIATE THE EFFECT OF GH ON JAK2/STAT5 ACTIVATION AND IGF-I GENE EXPRESSION IN HEPG2 CELLS
    Ocaranza, Paula
    Iniguez, German
    Cecilia Johnson, Maria
    Cassorla, Fernando
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 125 - 126
  • [28] Expression of functional prolactin receptors in nonpregnant human endometrium: Janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin
    Jabbour, HN
    Critchley, HOD
    Boddy, SC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07): : 2545 - 2553
  • [29] PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies.
    Masselli, Elena
    Mecucci, Cristina
    Gobbi, Giuliana
    Carubbi, Cecilia
    Bonomini, Sabrina
    Prezioso, Lucia
    Rossetti, Elena
    Caramatti, Cecilia
    Vitale, Marco
    Aversa, Franco
    BLOOD, 2012, 120 (21)
  • [30] Neuromedin U Peptide Activates STAT5 and S6 in a JAK-2 Dependent Manner and Promotes Erythroid Cell Growth in Primary Erythroid Progenitor Cells
    Lenzo, Rebecca
    Dua-Awereh, Martha
    Carroll, Martin
    Shetzline, Susan E.
    BLOOD, 2012, 120 (21)